Skip to main content
Premium Trial:

Request an Annual Quote

FlowJo, Becton Dickinson Partner for Single-Cell Analysis

NEW YORK (GenomeWeb) – FlowJo and Becton Dickinson said today that they have established a strategic relationship in the area of single-cell analysis.

Under the agreement, the companies will market FlowJo Envoy, cloud-based data-analysis software, with BD's FACSymphony, a cell analyzer enabling the simultaneous measurement of up to 50 characteristics of a single cell.

The combination is expected to enable researchers to improve workflows and collaborations, share their data in the cloud, and share single-cell analysis data in real time, the companies said.

Separately yesterday, Ashland, Oregon-based FlowJo and Canadian firm Cytapex Bioinformatics said that they are partnering to provide bioinformatics consulting and services in flow cytometry data analysis using the FlowJo application. The services complement researchers' work in flow cytometry and allows for custom pipeline development, including plugin "app" development for the FlowJo application, the companies said.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.